New antibody shot could block COVID-19 before it starts
Prevention
Ongoing
This study tests a new drug called VYD2311, a monoclonal antibody that sticks to the COVID-19 virus and stops it from entering cells. About 1,770 adults and teens aged 12 and older get a monthly shot of either VYD2311 or a placebo for 3 months. The goal is to see if it safely pre…
Phase: PHASE3 • Sponsor: Invivyd, Inc. • Aim: Prevention
Last updated May 09, 2026 19:03 UTC